Linkage Biosciences
Latest round
- Series B
Last raised
- Dec 2012
Total raised
- $5M
Investors
- 3
About Linkage Biosciences
Founded in 2004 and headquartered in San Francisco, US, Linkage Biosciences focuses on developing PCR typing technology. No significant changes in business strategy have been reported.Linkage Biosciences offers the LinkSeq PCR Typing Kits, which enable rapid genotyping with a streamlined workflow that minimizes contamination risks. These kits facilitate high-throughput processing of samples, allowing amplification in just 90 minutes. They are essential for areas such as HLA and KIR genotyping, as well as blood genotyping for RH, ABO, and HPA.Linkage Biosciences generates revenue through direct sales of its LinkSeq PCR Typing Kits and related products to laboratories and research institutions. The business model includes B2B transactions, where customers order kits based on their genotyping needs. Revenue streams consist of both one-time kit purchases and ongoing accessory sales, such as the LinkSeq Wipe Test, which complements their core products. The company is focusing on designing innovative products that cater to evolving needs in genetic analysis, with a timeline for new product launches expected in the next 12 to 18 months. Additionally, Linkage aims to penetrate new geographic regions, particularly in Europe and Asia by 2015, to broaden its market presence.
Who invested in Linkage Biosciences
3 investors across 4 rounds
See all investors in Linkage Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Linkage Biosciences
Who invested in Linkage Biosciences?
Linkage Biosciences has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Linkage Biosciences raised?
Linkage Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Linkage Biosciences last raise money?
Linkage Biosciences's most recent round on record is a Series B, in Dec 2012.
What does Linkage Biosciences do?
Founded in 2004 and headquartered in San Francisco, US, Linkage Biosciences focuses on developing PCR typing technology.
Where is Linkage Biosciences headquartered?
Linkage Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Linkage Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Linkage Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Linkage Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.